Anavex Life Sciences Corp (AVXL)

[biotechnician]

CC Highlights:
1. 25.8 million in cash enough funding for the next 24 months. Grants include Rhett Foundation to be covered during course of trial and Australian Government which can reimburse 40% of expense of the AD trial.
2. Rhett on track to start in current half of 2018.
3. Alzheimers trial, phase 2/3 will be 48 weeks and start in next few months
4. PD trial. phase 2 will measure cognitive and motor improvements and will be 14 weeks and start in next few months.
5, During Q and A Dr. Missling said trials should start in the next couple of months (different than a few months) and all should start in 2018.
6, Extensive use of genetic biomarkers in precision medicine in all 3 trials to support better trial results.